• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默型痴呆中5-羟色胺S2受体减少的选择性。

The selectivity of the reduction of serotonin S2 receptors in Alzheimer-type dementia.

作者信息

Cross A J, Crow T J, Ferrier I N, Johnson J A

出版信息

Neurobiol Aging. 1986 Jan-Feb;7(1):3-7. doi: 10.1016/0197-4580(86)90019-9.

DOI:10.1016/0197-4580(86)90019-9
PMID:2869422
Abstract

The high-affinity binding of thirteen ligands to putative neurotransmitter receptors was studied in temporal cortex of control and Alzheimer-type dementia (ATD) patients. A selective reduction of serotonin S2 receptors was observed in the ATD patients, to 57% of controls with no change in S1 receptors. Of the other ligand binding sites studied, only 3H-flunitrazepam binding was significantly reduced, to 84% of controls. Ligand binding sites which were unchanged in ATD temporal cortex included those labelled by adrenergic, adenosine, histamine, opiate, GABA, benzodiazepine and cholinergic ligands.

摘要

在对照患者和阿尔茨海默型痴呆(ATD)患者的颞叶皮质中,研究了13种配体与假定神经递质受体的高亲和力结合情况。在ATD患者中观察到血清素S2受体选择性减少,降至对照组的57%,而S1受体无变化。在所研究的其他配体结合位点中,只有3H-氟硝西泮结合显著减少,降至对照组的84%。在ATD颞叶皮质中未发生变化的配体结合位点包括那些由肾上腺素能、腺苷、组胺、阿片、GABA、苯二氮卓和胆碱能配体标记的位点。

相似文献

1
The selectivity of the reduction of serotonin S2 receptors in Alzheimer-type dementia.阿尔茨海默型痴呆中5-羟色胺S2受体减少的选择性。
Neurobiol Aging. 1986 Jan-Feb;7(1):3-7. doi: 10.1016/0197-4580(86)90019-9.
2
Serotonin receptor changes in dementia of the Alzheimer type.阿尔茨海默型痴呆中的血清素受体变化
J Neurochem. 1984 Dec;43(6):1574-81. doi: 10.1111/j.1471-4159.1984.tb06081.x.
3
Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type.阿尔茨海默型老年痴呆症新皮质和海马体中神经递质受体系统的研究。
J Neurol Sci. 1984 May;64(2):109-17. doi: 10.1016/0022-510x(84)90029-7.
4
Changes in benzodiazepine receptors in Alzheimer-type dementia.阿尔茨海默型痴呆中苯二氮䓬受体的变化。
Ann Neurol. 1988 Apr;23(4):404-6. doi: 10.1002/ana.410230419.
5
Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease.
Science. 1985 Jul 19;229(4710):289-91. doi: 10.1126/science.2861661.
6
Drug and transmitter receptors in human brain. Characterization and localization of serotonin, dopamine and adrenergic receptors.人类大脑中的药物和递质受体。5-羟色胺、多巴胺和肾上腺素能受体的特性与定位。
Acta Neurol Belg. 1986 Mar-Apr;86(2):61-129.
7
Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides.阿尔茨海默型痴呆、抑郁症患者及自杀者大脑中的神经递质受体和单胺代谢产物。
Neuropharmacology. 1984 Dec;23(12B):1561-9. doi: 10.1016/0028-3908(84)90100-x.
8
High-molecular-weight forms of somatostatin are reduced in Alzheimer's disease and Down's syndrome.阿尔茨海默病和唐氏综合征中,高分子量形式的生长抑素减少。
Neurosci Lett. 1986 Jan 16;63(2):141-6. doi: 10.1016/0304-3940(86)90051-0.
9
Somatostatin and vasoactive intestinal polypeptide in postmortem brains from patients with Alzheimer-type dementia.阿尔茨海默病型痴呆患者尸检大脑中的生长抑素和血管活性肠肽
Neurosci Lett. 1984 Nov 23;52(1-2):73-8. doi: 10.1016/0304-3940(84)90353-7.
10
Regional distribution of neurotransmitter receptors in the visual structures of the rat brain.
Biomed Biochim Acta. 1984;43(10):1119-25.

引用本文的文献

1
The GABAergic system in Alzheimer's disease: a systematic review with meta-analysis.阿尔茨海默病中的 GABA 能系统:系统评价与荟萃分析。
Mol Psychiatry. 2023 Dec;28(12):5025-5036. doi: 10.1038/s41380-023-02140-w. Epub 2023 Jul 7.
2
Positron emission tomography imaging of serotonin degeneration and beta-amyloid deposition in late-life depression evaluated with multi-modal partial least squares.采用多模态偏最小二乘法对晚年抑郁症的血清素退化和β-淀粉样蛋白沉积进行正电子发射断层扫描成像。
Transl Psychiatry. 2021 Sep 13;11(1):473. doi: 10.1038/s41398-021-01539-9.
3
Towards a Better Understanding of GABAergic Remodeling in Alzheimer's Disease.
深入了解阿尔茨海默病中的γ-氨基丁酸能重塑
Int J Mol Sci. 2017 Aug 21;18(8):1813. doi: 10.3390/ijms18081813.
4
Molecular imaging of serotonin degeneration in mild cognitive impairment.轻度认知障碍中5-羟色胺退变的分子成像
Neurobiol Dis. 2017 Sep;105:33-41. doi: 10.1016/j.nbd.2017.05.007. Epub 2017 May 13.
5
Association between serotonin denervation and resting-state functional connectivity in mild cognitive impairment.轻度认知障碍中血清素去神经支配与静息态功能连接之间的关联
Hum Brain Mapp. 2017 Jul;38(7):3391-3401. doi: 10.1002/hbm.23595. Epub 2017 Apr 5.
6
Plasma BDNF levels are correlated with aggressiveness in patients with amnestic mild cognitive impairment or Alzheimer disease.血浆脑源性神经营养因子水平与遗忘型轻度认知障碍或阿尔茨海默病患者的攻击性相关。
J Neural Transm (Vienna). 2014 Apr;121(4):433-41. doi: 10.1007/s00702-013-1121-y. Epub 2013 Nov 20.
7
Differential involvement of hippocampal serotonin1A receptors and re-uptake sites in non-cognitive behaviors of Alzheimer's disease.海马体 5-羟色胺 1A 受体和再摄取位点在阿尔茨海默病非认知行为中的差异参与。
Psychopharmacology (Berl). 2011 Feb;213(2-3):431-9. doi: 10.1007/s00213-010-1936-2. Epub 2010 Jul 13.
8
SPECT imaging of GABA(A)/benzodiazepine receptors and cerebral perfusion in mild cognitive impairment.SPECT 成像技术在轻中度认知障碍患者 GABA(A)/苯二氮䓬受体与脑灌注显像中的应用。
Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1156-63. doi: 10.1007/s00259-010-1409-1. Epub 2010 Mar 20.
9
Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease.胆碱能对阿尔茨海默病患者大脑对西酞普兰代谢反应的调节作用
Brain. 2009 Feb;132(Pt 2):392-401. doi: 10.1093/brain/awn326. Epub 2009 Jan 19.
10
Selective loss of P2Y2 nucleotide receptor immunoreactivity is associated with Alzheimer's disease neuropathology.P2Y2核苷酸受体免疫反应性的选择性丧失与阿尔茨海默病神经病理学相关。
J Neural Transm (Vienna). 2008 Aug;115(8):1165-72. doi: 10.1007/s00702-008-0067-y. Epub 2008 May 28.